HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A K McMillan Selected Research

Drug Therapy (Chemotherapy)

1/2020Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.
4/2008IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A K McMillan Research Topics

Disease

1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020
1Lymphoma (Lymphomas)
04/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2008

Drug/Important Bio-Agent (IBA)

1R-CHOP protocolIBA
01/2020
1IceIBA
04/2008
1IfosfamideFDA LinkGeneric
04/2008
1Epirubicin (Ellence)FDA LinkGeneric
04/2008
1Carboplatin (JM8)FDA LinkGeneric
04/2008
1Rituximab (Mabthera)FDA Link
04/2008
1Etoposide (VP 16)FDA LinkGeneric
04/2008

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2020 - 04/2008
1Therapeutics
04/2008
1Autologous Transplantation
04/2008
1Salvage Therapy
04/2008
1Stem Cell Transplantation
04/2008